The Alexander von Humboldt Foundation, established by the German government in 1953, promotes academic cooperation and exchange among scientists and scholars from Germany and abroad. The foundation has bestowed this year's award to Professor Suck-Joo Na of KAIST's Mechanical Engineering Department in recognition of his lifetime achievements.
Professor Na's main interests are in the fields of arc and laser welding, computational fluid dynamics simulation, residual stress and distortion, and design of welded structures. He has received numerous honors and awards including the Research Fellowship Award from the Alexander von Humboldt Foundation (1989), the Excellent Research Paper Award from the Korean Welding and Joining Society (1993), the Charles H. Jennings Memorial Award from the American Welding Society (2003), and the Yoshiaki Arata Award from the International Institute of Welding (2014).
The Humboldt Research Award is granted annually to up to 100 academics whose fundamental discoveries, new theories, or insights have had a significant impact on their own discipline and who are expected to continue producing cutting-edge achievements in the future.
The award winners also receive a research grant of 60,000 Euros and are invited to work up to one year with colleagues at research institutions in Germany. Nominations for the award are made only by established academic institutions in Germany.
Professor Na will collaborate with a research team led by Professor Michael Rethmeier at the Berlin-based Federal Institute for Materials Research and Testing (BAM) to conduct research in laser welding and selective laser melting, as well as the mathematical analysis of these manufacturing processes from July 2017 to the end of February 2018.
Structural batteries are used in industries such as eco-friendly, energy-based automobiles, mobility, and aerospace, and they must simultaneously meet the requirements of high energy density for energy storage and high load-bearing capacity. Conventional structural battery technology has struggled to enhance both functions concurrently. However, KAIST researchers have succeeded in developing foundational technology to address this issue. < Photo 1. (From left) Professor Seong Su Kim, PhD
2024-11-27< Photo of ImpriMed CEO Sungwon Lim’s lecture > The Office of Global Initiative at KAIST successfully hosted the 2024 Global Startup Internship Seminar (GSIS) from Wednesday, November 20, to Friday, November 22. Now in its third year, following the 2022 Global Startup Internship Fair, the GSIS aims to introduce KAIST students to internship opportunities at U.S.-based startups and encourage participation in global internship programs, particularly for students with entrepreneu
2024-11-25A joint research team from Korea and the United States has developed next-generation, high-resolution image sensor technology with higher power efficiency and a smaller size compared to existing sensors. Notably, they have secured foundational technology for ultra-high-resolution shortwave infrared (SWIR) image sensors, an area currently dominated by Sony, paving the way for future market entry. KAIST (represented by President Kwang Hyung Lee) announced on the 20th of November that a research t
2024-11-22KAIST's quadrupedal walking robot "RAIBO", which can run seamlessly on sandy beaches, has now evolved into "RAIBO2"and achieved the groundbreaking milestone by becomeing the world's first quadrupedal robot to successfully complete a full-course marathon in an official event. < Photo 1. A group photo of RAIBO2 and the team after completing the full-course marathon > KAIST (President Kwang Hyung Lee) announced on the 17th of November that Professor Je Min Hwangbo's research team of t
2024-11-17< Photo 1. (From left) Professor Heung Kyu Lee, KAIST Department of Biological Sciences, and Dr. Keun Bon Ku > Immunotherapy, which enhances the immune system's T cell response to eliminate cancer cells, has emerged as a key approach in cancer treatment. However, in the case of glioblastoma, an aggressive and treatment-resistant brain tumor, numerous clinical trials have failed to confirm their efficacy. Korean researchers have recently analyzed the mechanisms that cause T cell exhaus
2024-11-15